Intermede Investment Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-605,139
Closed -$44.3M 28
2020
Q2
$44.3M Buy
605,139
+12,910
+2% +$917K 2.17% 22
2020
Q1
$39.3M Sell
592,229
-10,016
-2% -$706K 2.32% 20
2019
Q4
$41.5M Buy
602,245
+9,777
+2% +$667K 2.1% 22
2019
Q3
$43.6M Sell
592,468
-106,220
-15% -$7.71M 2.42% 21
2019
Q2
$50.1M Sell
698,688
-150,341
-18% -$10.7M 2.96% 19
2019
Q1
$58.2M Buy
849,029
+102,314
+14% +$6.61M 3.62% 18
2018
Q4
$44.4M Buy
746,715
+37,400
+5% +$2.34M 3.55% 16
2018
Q3
$47.5M Buy
709,315
+28,356
+4% +$1.89M 3.56% 17
2018
Q2
$44.1M Buy
+680,959
New +$44.5M 3.49% 17
2016
Q1
Sell
-254,535
Closed -$17M 30
2015
Q4
$17M Buy
+254,535
New +$16.9M 2.87% 20

Other funds holding CL

Intermede Investment Partners's CL Position: Q3 2020 in Review

Intermede Investment Partners sold out of Colgate-Palmolive (CL) in Q3 2020, closing a stake of 605,139 shares — an estimated $44.3M sold.

Intermede Investment Partners first reported a position in CL in Q4 2015 and held it in 10 quarters. The position peaked at $58.2M in Q1 2019. 1,530 funds tracked by Wall St. Rank hold CL as of Q3 2020.

  • Intermede Investment Partners reported no remaining Colgate-Palmolive position as of Q3 2020 after selling out during the quarter.
  • Intermede Investment Partners sold 605,139 Colgate-Palmolive shares in Q3 2020, an estimated $44.3M.
  • Intermede Investment Partners first reported a position in Colgate-Palmolive in Q4 2015 and held it in 10 quarters.
  • Intermede Investment Partners's Colgate-Palmolive position peaked at $58.2M in Q1 2019.
  • 1,530 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2020.

Based on Intermede Investment Partners's 13F filing for Q3 2020, filed 29 Oct 2020.